ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CRISPR Gene Testing and Diagnostics Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-16O11739
Home | Market Reports | Science| Biological Sciences
Global CRISPR Gene Testing and Diagnostics Market Research Report 2022
BUY CHAPTERS

Global CRISPR Gene Testing and Diagnostics Market Research Report 2024

Code: QYRE-Auto-16O11739
Report
April 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
10X Genomics
Aelian Biotechnology
Beckman Coulter
Becton Dickinson and Company
binx health
bioMérieux
Bio Rad Laboratories
Caspr Biotech
ERS ​​Genomics
FASMAC
Illumina Inc
Janssen Diagnostics
Locus Biosciences
Mammoth Biosciences
NRGene
Roche
Sherlock Biosciences
Thermo Fisher Scientific
Vivlion

CRISPR Gene Testing and Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

CRISPR Gene Testing and Diagnostics Market

CRISPR Gene Testing and Diagnostics Market

The global CRISPR Gene Testing and Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for CRISPR Gene Testing and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Gene Testing and Diagnostics.

Report Scope

The CRISPR Gene Testing and Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR Gene Testing and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR Gene Testing and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of CRISPR Gene Testing and Diagnostics Market Report

Report Metric Details
Report Name CRISPR Gene Testing and Diagnostics Market
CAGR 5%
Segment by Type
  • Animals
  • Plants
  • Pathogens
  • Others
Segment by Application
  • Medical Industry
  • Agriculture
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company 10x Genomics, Aelian Biotechnology, Agilent Technologies, Axxam, Beckman Coulter, Becton, Dickinson and Company, Binx Health, bioMérieux, Bio-Rad Laboratories, Caspr Biotech, ERS Genomics, FASMAC, Illumina, Janssen Diagnostics, Locus Biosciences, Mammoth Biosciences, NRGene, Roche, Sherlock Biosciences, Thermo Fisher Scientific, Vivlion
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of CRISPR Gene Testing and Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CRISPR Gene Testing and Diagnostics Market report?

Ans: The main players in the CRISPR Gene Testing and Diagnostics Market are 10x Genomics, Aelian Biotechnology, Agilent Technologies, Axxam, Beckman Coulter, Becton, Dickinson and Company, Binx Health, bioMérieux, Bio-Rad Laboratories, Caspr Biotech, ERS Genomics, FASMAC, Illumina, Janssen Diagnostics, Locus Biosciences, Mammoth Biosciences, NRGene, Roche, Sherlock Biosciences, Thermo Fisher Scientific, Vivlion

What are the Application segmentation covered in the CRISPR Gene Testing and Diagnostics Market report?

Ans: The Applications covered in the CRISPR Gene Testing and Diagnostics Market report are Medical Industry, Agriculture, Others

What are the Type segmentation covered in the CRISPR Gene Testing and Diagnostics Market report?

Ans: The Types covered in the CRISPR Gene Testing and Diagnostics Market report are Animals, Plants, Pathogens, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Animals
1.2.3 Plants
1.2.4 Pathogens
1.2.5 Others
1.3 Market by Application
1.3.1 Global CRISPR Gene Testing and Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Industry
1.3.3 Agriculture
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR Gene Testing and Diagnostics Market Perspective (2019-2030)
2.2 CRISPR Gene Testing and Diagnostics Growth Trends by Region
2.2.1 Global CRISPR Gene Testing and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CRISPR Gene Testing and Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 CRISPR Gene Testing and Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 CRISPR Gene Testing and Diagnostics Market Dynamics
2.3.1 CRISPR Gene Testing and Diagnostics Industry Trends
2.3.2 CRISPR Gene Testing and Diagnostics Market Drivers
2.3.3 CRISPR Gene Testing and Diagnostics Market Challenges
2.3.4 CRISPR Gene Testing and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR Gene Testing and Diagnostics Players by Revenue
3.1.1 Global Top CRISPR Gene Testing and Diagnostics Players by Revenue (2019-2024)
3.1.2 Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global CRISPR Gene Testing and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR Gene Testing and Diagnostics Revenue
3.4 Global CRISPR Gene Testing and Diagnostics Market Concentration Ratio
3.4.1 Global CRISPR Gene Testing and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR Gene Testing and Diagnostics Revenue in 2023
3.5 CRISPR Gene Testing and Diagnostics Key Players Head office and Area Served
3.6 Key Players CRISPR Gene Testing and Diagnostics Product Solution and Service
3.7 Date of Enter into CRISPR Gene Testing and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR Gene Testing and Diagnostics Breakdown Data by Type
4.1 Global CRISPR Gene Testing and Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Type (2025-2030)
5 CRISPR Gene Testing and Diagnostics Breakdown Data by Application
5.1 Global CRISPR Gene Testing and Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CRISPR Gene Testing and Diagnostics Market Size (2019-2030)
6.2 North America CRISPR Gene Testing and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CRISPR Gene Testing and Diagnostics Market Size by Country (2019-2024)
6.4 North America CRISPR Gene Testing and Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR Gene Testing and Diagnostics Market Size (2019-2030)
7.2 Europe CRISPR Gene Testing and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CRISPR Gene Testing and Diagnostics Market Size by Country (2019-2024)
7.4 Europe CRISPR Gene Testing and Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific CRISPR Gene Testing and Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR Gene Testing and Diagnostics Market Size (2019-2030)
9.2 Latin America CRISPR Gene Testing and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CRISPR Gene Testing and Diagnostics Market Size by Country (2019-2024)
9.4 Latin America CRISPR Gene Testing and Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Detail
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics CRISPR Gene Testing and Diagnostics Introduction
11.1.4 10x Genomics Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.1.5 10x Genomics Recent Development
11.2 Aelian Biotechnology
11.2.1 Aelian Biotechnology Company Detail
11.2.2 Aelian Biotechnology Business Overview
11.2.3 Aelian Biotechnology CRISPR Gene Testing and Diagnostics Introduction
11.2.4 Aelian Biotechnology Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.2.5 Aelian Biotechnology Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies CRISPR Gene Testing and Diagnostics Introduction
11.3.4 Agilent Technologies Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.3.5 Agilent Technologies Recent Development
11.4 Axxam
11.4.1 Axxam Company Detail
11.4.2 Axxam Business Overview
11.4.3 Axxam CRISPR Gene Testing and Diagnostics Introduction
11.4.4 Axxam Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.4.5 Axxam Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Detail
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter CRISPR Gene Testing and Diagnostics Introduction
11.5.4 Beckman Coulter Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.5.5 Beckman Coulter Recent Development
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Company Detail
11.6.2 Becton, Dickinson and Company Business Overview
11.6.3 Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Introduction
11.6.4 Becton, Dickinson and Company Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.6.5 Becton, Dickinson and Company Recent Development
11.7 Binx Health
11.7.1 Binx Health Company Detail
11.7.2 Binx Health Business Overview
11.7.3 Binx Health CRISPR Gene Testing and Diagnostics Introduction
11.7.4 Binx Health Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.7.5 Binx Health Recent Development
11.8 bioMérieux
11.8.1 bioMérieux Company Detail
11.8.2 bioMérieux Business Overview
11.8.3 bioMérieux CRISPR Gene Testing and Diagnostics Introduction
11.8.4 bioMérieux Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.8.5 bioMérieux Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Detail
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Introduction
11.9.4 Bio-Rad Laboratories Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Caspr Biotech
11.10.1 Caspr Biotech Company Detail
11.10.2 Caspr Biotech Business Overview
11.10.3 Caspr Biotech CRISPR Gene Testing and Diagnostics Introduction
11.10.4 Caspr Biotech Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.10.5 Caspr Biotech Recent Development
11.11 ERS Genomics
11.11.1 ERS Genomics Company Detail
11.11.2 ERS Genomics Business Overview
11.11.3 ERS Genomics CRISPR Gene Testing and Diagnostics Introduction
11.11.4 ERS Genomics Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.11.5 ERS Genomics Recent Development
11.12 FASMAC
11.12.1 FASMAC Company Detail
11.12.2 FASMAC Business Overview
11.12.3 FASMAC CRISPR Gene Testing and Diagnostics Introduction
11.12.4 FASMAC Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.12.5 FASMAC Recent Development
11.13 Illumina
11.13.1 Illumina Company Detail
11.13.2 Illumina Business Overview
11.13.3 Illumina CRISPR Gene Testing and Diagnostics Introduction
11.13.4 Illumina Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.13.5 Illumina Recent Development
11.14 Janssen Diagnostics
11.14.1 Janssen Diagnostics Company Detail
11.14.2 Janssen Diagnostics Business Overview
11.14.3 Janssen Diagnostics CRISPR Gene Testing and Diagnostics Introduction
11.14.4 Janssen Diagnostics Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.14.5 Janssen Diagnostics Recent Development
11.15 Locus Biosciences
11.15.1 Locus Biosciences Company Detail
11.15.2 Locus Biosciences Business Overview
11.15.3 Locus Biosciences CRISPR Gene Testing and Diagnostics Introduction
11.15.4 Locus Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.15.5 Locus Biosciences Recent Development
11.16 Mammoth Biosciences
11.16.1 Mammoth Biosciences Company Detail
11.16.2 Mammoth Biosciences Business Overview
11.16.3 Mammoth Biosciences CRISPR Gene Testing and Diagnostics Introduction
11.16.4 Mammoth Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.16.5 Mammoth Biosciences Recent Development
11.17 NRGene
11.17.1 NRGene Company Detail
11.17.2 NRGene Business Overview
11.17.3 NRGene CRISPR Gene Testing and Diagnostics Introduction
11.17.4 NRGene Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.17.5 NRGene Recent Development
11.18 Roche
11.18.1 Roche Company Detail
11.18.2 Roche Business Overview
11.18.3 Roche CRISPR Gene Testing and Diagnostics Introduction
11.18.4 Roche Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.18.5 Roche Recent Development
11.19 Sherlock Biosciences
11.19.1 Sherlock Biosciences Company Detail
11.19.2 Sherlock Biosciences Business Overview
11.19.3 Sherlock Biosciences CRISPR Gene Testing and Diagnostics Introduction
11.19.4 Sherlock Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.19.5 Sherlock Biosciences Recent Development
11.20 Thermo Fisher Scientific
11.20.1 Thermo Fisher Scientific Company Detail
11.20.2 Thermo Fisher Scientific Business Overview
11.20.3 Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Introduction
11.20.4 Thermo Fisher Scientific Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.20.5 Thermo Fisher Scientific Recent Development
11.21 Vivlion
11.21.1 Vivlion Company Detail
11.21.2 Vivlion Business Overview
11.21.3 Vivlion CRISPR Gene Testing and Diagnostics Introduction
11.21.4 Vivlion Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024)
11.21.5 Vivlion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
10X Genomics
Aelian Biotechnology
Beckman Coulter
Becton Dickinson and Company
binx health
bioMérieux
Bio Rad Laboratories
Caspr Biotech
ERS ​​Genomics
FASMAC
Illumina Inc
Janssen Diagnostics
Locus Biosciences
Mammoth Biosciences
NRGene
Roche
Sherlock Biosciences
Thermo Fisher Scientific
Vivlion
List of Tables
    Table 1. Global CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Animals
    Table 3. Key Players of Plants
    Table 4. Key Players of Pathogens
    Table 5. Key Players of Others
    Table 6. Global CRISPR Gene Testing and Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global CRISPR Gene Testing and Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global CRISPR Gene Testing and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global CRISPR Gene Testing and Diagnostics Market Share by Region (2019-2024)
    Table 10. Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global CRISPR Gene Testing and Diagnostics Market Share by Region (2025-2030)
    Table 12. CRISPR Gene Testing and Diagnostics Market Trends
    Table 13. CRISPR Gene Testing and Diagnostics Market Drivers
    Table 14. CRISPR Gene Testing and Diagnostics Market Challenges
    Table 15. CRISPR Gene Testing and Diagnostics Market Restraints
    Table 16. Global CRISPR Gene Testing and Diagnostics Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global CRISPR Gene Testing and Diagnostics Market Share by Players (2019-2024)
    Table 18. Global Top CRISPR Gene Testing and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Gene Testing and Diagnostics as of 2023)
    Table 19. Ranking of Global Top CRISPR Gene Testing and Diagnostics Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by CRISPR Gene Testing and Diagnostics Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players CRISPR Gene Testing and Diagnostics Product Solution and Service
    Table 23. Date of Enter into CRISPR Gene Testing and Diagnostics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global CRISPR Gene Testing and Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Type (2019-2024)
    Table 27. Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Type (2025-2030)
    Table 29. Global CRISPR Gene Testing and Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Application (2019-2024)
    Table 31. Global CRISPR Gene Testing and Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global CRISPR Gene Testing and Diagnostics Revenue Market Share by Application (2025-2030)
    Table 33. North America CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America CRISPR Gene Testing and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America CRISPR Gene Testing and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe CRISPR Gene Testing and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe CRISPR Gene Testing and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America CRISPR Gene Testing and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America CRISPR Gene Testing and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 48. 10x Genomics Company Detail
    Table 49. 10x Genomics Business Overview
    Table 50. 10x Genomics CRISPR Gene Testing and Diagnostics Product
    Table 51. 10x Genomics Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 52. 10x Genomics Recent Development
    Table 53. Aelian Biotechnology Company Detail
    Table 54. Aelian Biotechnology Business Overview
    Table 55. Aelian Biotechnology CRISPR Gene Testing and Diagnostics Product
    Table 56. Aelian Biotechnology Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 57. Aelian Biotechnology Recent Development
    Table 58. Agilent Technologies Company Detail
    Table 59. Agilent Technologies Business Overview
    Table 60. Agilent Technologies CRISPR Gene Testing and Diagnostics Product
    Table 61. Agilent Technologies Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 62. Agilent Technologies Recent Development
    Table 63. Axxam Company Detail
    Table 64. Axxam Business Overview
    Table 65. Axxam CRISPR Gene Testing and Diagnostics Product
    Table 66. Axxam Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 67. Axxam Recent Development
    Table 68. Beckman Coulter Company Detail
    Table 69. Beckman Coulter Business Overview
    Table 70. Beckman Coulter CRISPR Gene Testing and Diagnostics Product
    Table 71. Beckman Coulter Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 72. Beckman Coulter Recent Development
    Table 73. Becton, Dickinson and Company Company Detail
    Table 74. Becton, Dickinson and Company Business Overview
    Table 75. Becton, Dickinson and Company CRISPR Gene Testing and Diagnostics Product
    Table 76. Becton, Dickinson and Company Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 77. Becton, Dickinson and Company Recent Development
    Table 78. Binx Health Company Detail
    Table 79. Binx Health Business Overview
    Table 80. Binx Health CRISPR Gene Testing and Diagnostics Product
    Table 81. Binx Health Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 82. Binx Health Recent Development
    Table 83. bioMérieux Company Detail
    Table 84. bioMérieux Business Overview
    Table 85. bioMérieux CRISPR Gene Testing and Diagnostics Product
    Table 86. bioMérieux Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 87. bioMérieux Recent Development
    Table 88. Bio-Rad Laboratories Company Detail
    Table 89. Bio-Rad Laboratories Business Overview
    Table 90. Bio-Rad Laboratories CRISPR Gene Testing and Diagnostics Product
    Table 91. Bio-Rad Laboratories Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 92. Bio-Rad Laboratories Recent Development
    Table 93. Caspr Biotech Company Detail
    Table 94. Caspr Biotech Business Overview
    Table 95. Caspr Biotech CRISPR Gene Testing and Diagnostics Product
    Table 96. Caspr Biotech Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 97. Caspr Biotech Recent Development
    Table 98. ERS Genomics Company Detail
    Table 99. ERS Genomics Business Overview
    Table 100. ERS Genomics CRISPR Gene Testing and Diagnostics Product
    Table 101. ERS Genomics Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 102. ERS Genomics Recent Development
    Table 103. FASMAC Company Detail
    Table 104. FASMAC Business Overview
    Table 105. FASMAC CRISPR Gene Testing and Diagnostics Product
    Table 106. FASMAC Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 107. FASMAC Recent Development
    Table 108. Illumina Company Detail
    Table 109. Illumina Business Overview
    Table 110. Illumina CRISPR Gene Testing and Diagnostics Product
    Table 111. Illumina Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 112. Illumina Recent Development
    Table 113. Janssen Diagnostics Company Detail
    Table 114. Janssen Diagnostics Business Overview
    Table 115. Janssen Diagnostics CRISPR Gene Testing and Diagnostics Product
    Table 116. Janssen Diagnostics Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 117. Janssen Diagnostics Recent Development
    Table 118. Locus Biosciences Company Detail
    Table 119. Locus Biosciences Business Overview
    Table 120. Locus Biosciences CRISPR Gene Testing and Diagnostics Product
    Table 121. Locus Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 122. Locus Biosciences Recent Development
    Table 123. Mammoth Biosciences Company Detail
    Table 124. Mammoth Biosciences Business Overview
    Table 125. Mammoth Biosciences CRISPR Gene Testing and Diagnostics Product
    Table 126. Mammoth Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 127. Mammoth Biosciences Recent Development
    Table 128. NRGene Company Detail
    Table 129. NRGene Business Overview
    Table 130. NRGene CRISPR Gene Testing and Diagnostics Product
    Table 131. NRGene Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 132. NRGene Recent Development
    Table 133. Roche Company Detail
    Table 134. Roche Business Overview
    Table 135. Roche CRISPR Gene Testing and Diagnostics Product
    Table 136. Roche Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 137. Roche Recent Development
    Table 138. Sherlock Biosciences Company Detail
    Table 139. Sherlock Biosciences Business Overview
    Table 140. Sherlock Biosciences CRISPR Gene Testing and Diagnostics Product
    Table 141. Sherlock Biosciences Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 142. Sherlock Biosciences Recent Development
    Table 143. Thermo Fisher Scientific Company Detail
    Table 144. Thermo Fisher Scientific Business Overview
    Table 145. Thermo Fisher Scientific CRISPR Gene Testing and Diagnostics Product
    Table 146. Thermo Fisher Scientific Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 147. Thermo Fisher Scientific Recent Development
    Table 148. Vivlion Company Detail
    Table 149. Vivlion Business Overview
    Table 150. Vivlion CRISPR Gene Testing and Diagnostics Product
    Table 151. Vivlion Revenue in CRISPR Gene Testing and Diagnostics Business (2019-2024) & (US$ Million)
    Table 152. Vivlion Recent Development
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global CRISPR Gene Testing and Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global CRISPR Gene Testing and Diagnostics Market Share by Type: 2023 VS 2030
    Figure 3. Animals Features
    Figure 4. Plants Features
    Figure 5. Pathogens Features
    Figure 6. Others Features
    Figure 7. Global CRISPR Gene Testing and Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global CRISPR Gene Testing and Diagnostics Market Share by Application: 2023 VS 2030
    Figure 9. Medical Industry Case Studies
    Figure 10. Agriculture Case Studies
    Figure 11. Others Case Studies
    Figure 12. CRISPR Gene Testing and Diagnostics Report Years Considered
    Figure 13. Global CRISPR Gene Testing and Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global CRISPR Gene Testing and Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global CRISPR Gene Testing and Diagnostics Market Share by Region: 2023 VS 2030
    Figure 16. Global CRISPR Gene Testing and Diagnostics Market Share by Players in 2023
    Figure 17. Global Top CRISPR Gene Testing and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Gene Testing and Diagnostics as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by CRISPR Gene Testing and Diagnostics Revenue in 2023
    Figure 19. North America CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America CRISPR Gene Testing and Diagnostics Market Share by Country (2019-2030)
    Figure 21. United States CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe CRISPR Gene Testing and Diagnostics Market Share by Country (2019-2030)
    Figure 25. Germany CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific CRISPR Gene Testing and Diagnostics Market Share by Region (2019-2030)
    Figure 33. China CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America CRISPR Gene Testing and Diagnostics Market Share by Country (2019-2030)
    Figure 41. Mexico CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa CRISPR Gene Testing and Diagnostics Market Share by Country (2019-2030)
    Figure 45. Turkey CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia CRISPR Gene Testing and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. 10x Genomics Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 48. Aelian Biotechnology Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 49. Agilent Technologies Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 50. Axxam Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 51. Beckman Coulter Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 52. Becton, Dickinson and Company Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 53. Binx Health Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 54. bioMérieux Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 55. Bio-Rad Laboratories Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 56. Caspr Biotech Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 57. ERS Genomics Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 58. FASMAC Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 59. Illumina Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 60. Janssen Diagnostics Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 61. Locus Biosciences Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 62. Mammoth Biosciences Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 63. NRGene Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 64. Roche Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 65. Sherlock Biosciences Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 66. Thermo Fisher Scientific Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 67. Vivlion Revenue Growth Rate in CRISPR Gene Testing and Diagnostics Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global CRISPR Gene Detection and Diagnostic Market Research Report 2024
Global Predictive Genetic Testing and Genomics Market Research Report 2025
Global Genetic Disease Diagnosis Market Research Report 2024
Global PCR Molecular Diagnostics Market Research Report 2024
Gene Therapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gene Therapy Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non invasive Prenatal Genetic Testing Market Research Report 2025
Global Whole Genome Testing Services Market Research Report 2025
Global Cellular and Gene Therapy Product Market Research Report 2025
Cell and Gene Therapy Bioassay Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
DNA Probe based Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
DNA Sequencing In Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
High density Multiplexed Diagnostic Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Adenovirus Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Precision Diagnostic Market Research Report 2024
Molecular Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fetal Monitoring and Diagnostics Test Market Research Report 2024
Pharmacogenomics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Automated Clinical Diagnostic System Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions